山东汉族人群ApoE基因多态性与房颤的相关性
Association of ApoE gene polymorphism and risk of atrial fibrillation among Han people in Shandong Province

DOI: 10.6040/j.issn.1671-7554.0.2017.097

Keywords: 多态性,房颤,炎症,载脂蛋白E,氧化应激,
Polymorphism,Inflammation,Oxidative stress,Apolipoprotein E,Atrial fibrillation

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Ruiz JR, Labayen I, Ortega FB, et al. Birth weight and blood lipid levels in Spanish adolescents: influence of selected APOE, APOC3 and PPARgamma2 gene polymorphisms. The AVENA Study[J]. BMC Med Genet, 2008, 9(10): 98.
[2]	Nalliah CJ, Sanders P, Kottkamp H, et al. The role of obesity in atrial fibrillation[J]. Eur Heart J, 2016, 37(20): 1565-1572.
[3]	Huebbe P, Lodge JK, Rimbach G. Implications of apolipoprotein E genotype on inflammation and vitamin E status[J]. Mol Nutr Food Res, 2010, 54(5): 623-630.
[4]	吴丹丹, 陈瑜, 张腾. 房颤发病机制研究新进展[J]. 中西医结合心脑血管病杂志, 2016, 4(12): 1342-1346.
[5]	Hu YF, Chen YJ, Lin YJ, et al. Inflammation and the pathogenesis of atrial fibrillation[J]. Nat Rev Cardiol, 2015, 12(4): 230-243.
[6]	Lee JJ, Yin X, Hoffmann U, et al. Relation of pericardial fat, intrathoracic fat, and abdominal visceral fat with incident AF(from the Framingham Heart Study)[J]. Am J Cardiol, 2016, 118(10): 1486-1492.
[7]	Eichner JE, Dunn ST, Perveen G, et al. 2002. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review[J]. Am J Epidemiol, 2002, 155(6): 487-495.
[8]	Zhu Y, Nwabuisi-Heath E, Dumanis SB, et al. APOE genotype alters glial activation and loss of synaptic markers in mice[J]. Glia, 2012, 60(4): 559-569.
[9]	Cheema AN, Bhatti A, Wang X, et al. APOE gene polymorphism and risk of coronary stenosis in Pakistani population[J]. Biomed Res Int, 2015: 1-5.
[10]	Abd El-Aziz TA, Mohamed RH. LDLR, ApoB and ApoE genes polymorphisms and classical risk factors in premature coronary artery disease[J]. Gene, 2016, 590(2): 263-269.
[11]	Raygani AV, Zahrai M, Raygani AV, et al. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran[J]. Neurosci Lett, 2005, 375(1): 1-6.
[12]	Das S, Kaul S, Jyothy A, et al. Association of APOE(E2, E3 and E4)gene variants and lipid levels in ischemic stroke, its subtypes and hemorrhagic stroke in a South Indian population[J]. Neurosci Lett, 2016, 628: 136-141.
[13]	Watanabe H, Tanabe N, Yagihara N, et al. Association between lipid profile and risk of atrial fibrillation[J]. Circ J, 2011, 75(12): 2767-2774.
[14]	Alonso A, Yin X, Roetker NS, et al. Blood lipids and the incidence of atrial fibrillation: the multi-Ethnic study of atherosclerosis and the framingham heart study[J]. J Am Heart Assoc, 2014, 3(5): 1211-1221.
[15]	魏涛涛, 郭雪娅. 心房颤动新型危险因素的研究进展[J]. 中国循环杂志, 2016, 31(7): 720-722.
[16]	Garcia-Sayan E, Patel M, Wassouf M, et al. Derivation and validation of E/e' ratio as a parameter in the evaluation of left atrial appendage thrombus formation in patients with nonvalvular atrial fibrillation[J]. Int J Cardiovasc Imaging, 2016, 32(9): 1349-1356.
[17]	Jofre-Monseny L, Minihane AM, Rimbach G. Impact of apoE genotype on oxidative stress, inflammation and disease risk[J]. Mol Nutr Food Res, 2008, 52(1): 131-145.
[18]	Velagaleti RS, Massaro J, Vasan RS, et al. Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study[J]. Circulation, 2009, 120(23): 2345-2351.
[19]	Karahan Z, Ugurlu M, U？aman B, et al. Relation between Apolipoprotein E gene polymorphism and severity of coronary artery disease in acute myocardial infarction[J]. Cardiol Res Pract, 2015: 1-4.
[20]	Raygani AV, Rahimi Z, Kharazi H, et al. Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer's disease[J]. Neurosci Lett, 2006, 408(1): 68-72.
[21]	Harada M, Van Wagoner DR, Nattel S. Role of inflammation in atrial fibrillation pathophysiology and management[J]. Circ J, 2015, 79(3): 495-502.
[22]	Rye KA, Barter PJ. Cardioprotective functions of HDLs[J]. J Lipid Res, 2014, 55(2): 168-179.
[23]	Guo Y, Lip GYH, Apostolakis S. Inflammation in atrial fibrillation[J]. J Am Coll Cardiol, 2012, 60(22): 2263-2270.
[24]	Yang KC, Dudley SC. Oxidative stress and atrial fibrillation: finding a missing piece to the puzzle[J]. Circulation, 2013, 128(16): 1724-1726.
[25]	Luscher TF. Atrial fibrillation: novel risk factors, mechanisms and ablation techniques[J]. Eur Heart J, 2016, 37(20): 1553-1555.
[26]	Scridon A, Dobreanu D, Chevalier P, et al. Inflammation, a link between obesity and atrial fibrillation[J]. Inflamm Res, 2015, 64(6): 383-393.
[27]	Torres-Perez E, Ledesma M, Garcia-Sobreviela MP, et al. Apolipoprotein E4 association with metabolic syndrome depends on body fatness[J]. Atherosclerosis, 2016, 245: 35-42.
[28]	Wong CX, Ganesan AN, Selvanayagam JB. Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions[J]. Eur Heart J, 2017, 38(17): 1294-1306.
[29]	Liu F, Li Y, Xu Y. Weight loss to prevent atrial fibrillation: The role of epicardial adipose tissue[J]. Int J Cardiol, 2016, 204: 124-129.
[30]	Lee JJ, Yin X, Hoffmann U, et al. Relation of pericardial fat, intrathoracic fat, and abdominal visceral fat with incident atrial fibrillation(from the Framingham Heart Study)[J]. Am J Cardiol, 2016, 118(10): 1486-1492.
[31]	Rollo J, Knight S, May HT, et al. Incidence of dementia in relation to genetic variants at PITX2, ZFHX3, and ApoE epsilon4 in atrial fibrillation patients[J]. Pacing Clin Electrophysiol, 2015, 38(2): 171-172.
[32]	Bas HA, Aksoy F, Icli A, et al. The association of plasma oxidative status and inflammation with the development of atrial fibrillation in patients presenting with ST elevation myocardial infarction[J]. Scand J Clin Lab Invest, 2017, 77(2): 77-82.

Full-Text